Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate.
about
Stereoselective sulphate conjugation of racemic terbutaline by human liver cytosol.Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity.Effects of terbutaline on basal thermogenesis of human skeletal muscle and Na-K pump after 1 week of oral use--a placebo controlled comparison with propranolol.Stereoselective pharmacokinetics and pharmacodynamics of anti-asthma agents.Difference in pulmonary absorption of inhaled terbutaline in healthy smokers and non-smokers.Intestinal permeability and its relevance for absorption and elimination.Stereoselectivity in clinical pharmacokinetics and drug development.Continuous Intestinal Absorption Model Based on the Convection-Diffusion Equation.The role of permeability in drug ADME/PK, interactions and toxicity--presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans.Stereochemistry in pharmacotherapy: when mirror images are not identical.Enantioselective disposition of albuterol in humans.Enantioselective assays in comparative bioavailability studies of racemic drug formulations: nice to know or need to know?Stereoselective glucuronidation of formoterol by human liver microsomesSympathomimetic enantiomers and asthma.Pharmacokinetics of Oral and Inhaled Terbutaline after Exercise in Trained Men.A validated HPTLC method for determination of terbutaline sulfate in biological samples: Application to pharmacokinetic study.Investigation of distribution and elimination of terbutaline sulfate in the perfused rat liver preparation.Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.Terbutaline sulfoconjugate: characterization and urinary excretion monitored by LC/ESI-MS/MS.Role of adrenergic receptor subtypes in the control of human placental blood vessels.Beta2-agonist eutomers: a rational option for the treatment of asthma?Pharmacokinetics of intravenous, single-dose tiotropium in subjects with different degrees of renal impairment.Enantioselective pharmacokinetics of ethotoin in humans following single oral doses of the racemate.Enantioselective Pharmacokinetics of Bambuterol in Preclinical Species: Does S-bambuterol Influence the Clearance of the R-antipode?Comparative pharmacokinetics and bile transformation of R-enantiomer and racemic bambuterol after single-dose intravenous, oral administration in rats and beagle dogs.Pharmacokinetics of terbutaline in chronic kidney disease.Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3.
P2860
Q34357768-0C3E8A0C-82A8-4335-9BF5-D75018A783A8Q34403642-6F1B3CB4-191C-4467-8DDC-823CDFD43745Q34403824-4CBA9178-7C94-46FA-9C3B-3907354B78B1Q34579642-B33187D8-D84D-4FE8-8436-4EAB74BA5857Q36242566-DE7BB376-1A00-41D6-8AA3-2833BC26AE3DQ36985043-46CD53C4-71D1-408D-A14D-319CEA444389Q37946823-20CACEB8-6D09-4B68-9546-A3AE2CCF509AQ38677027-AD41CC60-29EF-43D0-919E-27FCC2AEB40DQ39809409-2DC1B007-3EA4-445C-B3DF-7CD575D4DCDCQ40529605-16F9C453-BD61-4CDA-839C-5C277792F33CQ40957302-7FB3453E-5662-49E5-8917-21581EBB882EQ41113849-3E3B0B7C-A642-40EC-9BFA-65727BCE0364Q41609922-34337982-8682-4190-8B2D-E572DC33AD78Q41719837-3F52F4F6-382F-4A0F-835F-21BF25BDD259Q41828786-E2CEB5A3-0517-4032-A6D2-B2EF02B3C8F8Q42181905-6AA24C3F-6793-4360-9A62-D05C6612B9A8Q42742718-89CA7783-295C-4391-9DF1-E5A4990D8501Q43043824-ADD34468-FF9A-47C9-AE5E-2DE513B70861Q43113969-316446C5-A832-4977-A589-43DEFECF2B47Q44569769-DAE0A5F8-6438-4CD4-9265-56BA255F2AD9Q44726379-81B1C4AB-09C5-4362-8A2F-0D99088B11ECQ44745258-8C277073-0A6B-4511-A398-DD3A25C82581Q45309684-875F4290-11DB-4AC9-939A-3EA738F800B9Q46606172-DB8481D3-38AA-4BA5-BF1F-A475877359B6Q46830391-D90C34C2-3BD0-4AE8-9467-F0FDC190969AQ46898599-5FD211D0-5C87-4095-A31E-C31A389231DEQ50665001-C4CAD919-6D04-4EB5-82CD-A86A2A766350
P2860
Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate.
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Pharmacokinetic evaluation in ...... antiomers and as the racemate.
@ast
Pharmacokinetic evaluation in ...... antiomers and as the racemate.
@en
Pharmacokinetic evaluation in ...... antiomers and as the racemate.
@nl
type
label
Pharmacokinetic evaluation in ...... antiomers and as the racemate.
@ast
Pharmacokinetic evaluation in ...... antiomers and as the racemate.
@en
Pharmacokinetic evaluation in ...... antiomers and as the racemate.
@nl
prefLabel
Pharmacokinetic evaluation in ...... antiomers and as the racemate.
@ast
Pharmacokinetic evaluation in ...... antiomers and as the racemate.
@en
Pharmacokinetic evaluation in ...... antiomers and as the racemate.
@nl
P2093
P2860
P1476
Pharmacokinetic evaluation in ...... antiomers and as the racemate.
@en
P2093
P2860
P356
10.1111/J.1365-2125.1989.TB05334.X
P407
P577
1989-01-01T00:00:00Z